Want to see IL:NRGN full AI Analyst Report?
NRGN Stock Chart & Stats
204.80
0.03(0.96%)
At close: 4:00 PM EST
204.80
0.03(0.96%)
Day’s Range― - ―
52-Week Range190.80 - 310.00
Previous CloseN/A
Volume1.26K
Average Volume (3M)27.56K
Market Cap
₪28.52M
Enterprise Value5.76M
Total Cash (Recent Filing)₪5.30M
Total Debt (Recent Filing)₪181.00K
Price to Earnings (P/E)―
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,327,785
10 Day Avg. Volume57,803
30 Day Avg. Volume27,561
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.94
Price to Sales (P/S)2.64
P/FCF Ratio116.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue & Margin ReboundA sharp top-line inflection combined with materially improved gross margins indicates better unit economics and scaling of core services. If sustained, this durable shift supports longer-term path to operating leverage, stronger SaaS/service economics, and reduced reliance on one-off projects.
Proprietary PlatformOwnership of a specialized Genomics Suite is a durable competitive asset: it enables recurring licensing/service revenue, creates technical switching costs for customers in agriculture and life sciences, and supports ecosystem-driven expansion into breeding and research workflows.
Improved Cash GenerationReturn to positive operating cash flow signals improved cash conversion of operations and reduces near-term external funding needs. This directional improvement enhances financial flexibility to invest in R&D and commercial scaling over the coming months if cash generation is maintained.
Bears Say
Large Ongoing LossesSustained large operating and net losses materially hinder ability to produce shareholder returns and require continued scale-up to reach profitability. Persistent negative margins increase financing needs and constrain long-term investment in product and go-to-market capabilities.
Small, Volatile Free Cash FlowAlthough directionally positive, FCF is tiny and declined year-over-year, leaving cash generation unproven at scale. Small, volatile FCF limits capacity to self-fund growth initiatives and raises the probability of future external financing, which can dilute shareholders or increase leverage.
Equity Volatility & Negative ROENegative ROE and historical equity swings (including past negative equity) reflect capital erosion risk from cumulative losses. This structural weakness can impede access to favorable financing, limit strategic optionality, and undermine long-term investor confidence absent sustained profitability.
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 190.80 and its highest was 310.00 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is ₪28.52M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
Currently, no data Available
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,327,785 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
NRGene Technologies Ltd is an AI-powered genomics firm that designs sophisticated computational tools and advanced algorithms, serving clients globally across North America, Europe, the Middle East, Africa, and Asia Pacific. The company provides specialized software applications and complete, ready-to-use solutions for various sectors, including agricultural breeding, food technology, academia, research institutions, and agribiotech enterprises. Additionally, NRGene develops custom genetic panels tailored for a broad range of plants, from staple crops like wheat, canola, corn, soybeans, and maize to cannabis. Established in 2009, its headquarters are located in Ness Ziona, Israel.